Latest net income for BIOX: $-240M, below the Industrials sector average of $26B.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2026
Trailing 12 months ending Mar 2026
Loading...
Loading...
The latest net income for BIOX is $-240M as of March 2026. That compares with $-8.3M in the prior-year period — down 2833.2% year over year. That is below the Industrials sector average of $26B. Investors often review this figure alongside Bioceres Crop Solutions's historical trend and sector peers before judging valuation or financial health.
Over the past year, BIOX's net income moved from $-8.3M to $-240M — a 2833.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Bioceres Crop Solutions's operating scale or balance-sheet position.
Against Industrials companies, BIOX currently prints $-240M for net income, while the sector average sits near $26B. That is roughly 100.9% below the sector mean. Large gaps often invite a closer look at Bioceres Crop Solutions's growth, margins, and balance sheet.
A net income figure of $-240M for BIOX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Industrials average is about $26B. Explore the charts below for those layers of context.
After noting BIOX's net income ($-240M), review year-over-year change from $-8.3M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.